SMAD2 and familial hypercholesterolemia: In a hypercholesterolemia-driven mouse model of CAVD, cholesterol-lowering strategies reduced calcification but not fibrosis or Smad2 signaling, and this effect was attributed to the selective down-regulation of Smad6 [54].